Radiopharmaceuticals Market Report 2025 (Global Edition)

Global Radiopharmaceuticals Market Report 2025 Market Size Split by Radioisotope (Technetium 99m, Gallium 68, Iodine I, Fluorine 18, Copper 64, Strontium 89, Yttrium 90, Radium 223, Actinium 225, Lute...

Radiopharmaceuticals Market Report Description

We have various report editions of Radiopharmaceuticals Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Radiopharmaceuticals Market Insights Video

Competitive Landscape of the Radiopharmaceuticals Market

The competitive landscape of the Radiopharmaceuticals market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized Radiopharmaceuticals companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

May 2023: Notable American pharmaceutical business NorthStar Medical Radioisotopes formed a strategic agreement with Inhibrx, Inc. This partnership's main goal is to jointly research and produce cutting-edge radiopharmaceuticals that are painstakingly made to fight cancer. This collaboration represents a major step forward in the advancement of cancer care since radiopharmaceuticals play a crucial role in the field of medical imaging, acting as a diagnostic and therapeutic tool for cancer. (Source: https://www.northstarnm.com/northstar-medical-radioisotopes-and-inhibrx-enter-into-collaboration-agreement-for-the-development-and-production-of-radiopharmaceutical-candidates/)

Top Companies Market Share in Radiopharmaceuticals Industry: (In no particular order of Rank)

• Bayer AG
• Iso-Tex Diagnostics
• Inc
• Jubilant Pharmova Limited
• Novartis AG
• General Electric Company
• Lantheus Holdings
• Inc.
• Eli Lilly and Company
• Siemens AG
• Curium Pharma
• Cardinal Health Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Radiopharmaceuticals Market

Which Region Dominates the Radiopharmaceuticals Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. North America is witnessing an increase in the radiopharmaceuticals marketplace due to advancements in healthcare infrastructure, the growing prevalence of chronic sicknesses, and sturdy research and development sports. The area benefits from a strong regulatory framework, technological innovations in molecular imaging, and rising demand for customized medication. These elements contribute to increasing marketplace opportunities and funding in radiopharmaceuticals.

Which Region is Expanding at the Fastest CAGR?

Europe stands out as the fastest-growing region in the Radiopharmaceuticals market due to several compelling reasons. ? Europe's radiopharmaceuticals marketplace is expanding due to advancements in clinical imaging technology, growing healthcare expenditure, and growing incidences of chronic diseases. The location's sturdy emphasis on studies and development, coupled with supportive regulatory frameworks, fosters innovation and a marketplace boom. Growing adoption of PET and SPECT imaging techniques further drives demand for radiopharmaceuticals, positioning Europe as a big participant within the global marketplace.

 

The current report Scope analyzes Radiopharmaceuticals Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Radiopharmaceuticals

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 3250.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Radiopharmaceuticals market with a market size of USD 2564.31 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. The demand is amplified by the cancer prevalence.
• The Canada Radiopharmaceuticals market had a market share of USD 390.01 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. Canada's technological advancements.
• The Mexico Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 295.76 million in 2024.

Europe Radiopharmaceuticals

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 2437.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.

• The United Kingdom Radiopharmaceuticals market had a market share of USD 409.51 million in 2024 and is projected to grow at a CAGR of 10.1% during the forecast period. In the UK, Radiopharmaceuticals sales witness an upswing due to the regulatory approvals.
• The France Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 224.26 million in 2024.
• According to Cognitive Market Research, the Germany Radiopharmaceuticals market size was valued at USD 482.64 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. In Germany, Radiopharmaceuticals sales surged due to aging population.
• The Italy Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 209.63 million in 2024.
• The Russia Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 377.82 million in 2024.
• The Spain Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.4% during the forecast period with a market size of USD 199.88 million in 2024
• The Luxembourg Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 75.56 million in 2024.
• The Portugal Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 51.19 million in 2024.
• The Greece Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 29.25 million in 2024.
• Rest of Europe's Radiopharmaceuticals market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 377.82 million in 2024.

Asia Pacific Radiopharmaceuticals

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1868.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Radiopharmaceuticals market size was valued at USD 840.96 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. Radiopharmaceuticals sales surge in China due to the diagnostic demand.
• The Japan Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 257.89 million in 2024.
• The India Radiopharmaceuticals market had a market share of USD 224.26 million in 2024 and is projected to grow at a CAGR of 14.6% during the forecast period. India's government funding.
• The South Korea Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 186.88 million in 2024.
• The Australia Radiopharmaceuticals market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 97.18 million in 2024.
• The South East Asia Radiopharmaceuticals market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 128.95 million in 2024.
• The Rest of Asia Pacific Radiopharmaceuticals market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 132.68 million in 2024.

South America Radiopharmaceuticals

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 406.26million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Radiopharmaceuticals market size was valued at USD 173.88 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. Radiopharmaceuticals sales flourish in Brazil due to the R&D investment.
• Argentina Radiopharmaceuticals market had a market share of USD 68.25 million in 2024 and is projected to grow at a CAGR of 11.1% during the forecast period. Argentina's nuclear medicine growth.
• Colombia Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.0% during the forecast period with a market size of USD 36.16 million in 2024.
• Peru Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.4% during the forecast period with a market size of USD 33.31 million in 2024.
• Chile Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.5% during the forecast period with a market size of USD 29.25 million in 2024.
• The Rest of Latin America Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 65.41 million in 2024.

Middle East and Africa Radiopharmaceuticals

According to Cognitive Market Research, the global Radiopharmaceuticals market size was estimated at USD 8125.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 162.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031

• The GCC Countries Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.3% during the forecast period with a market size of USD 69.55 million in 2024. Radiopharmaceuticals sales flourish due to the precision medicine.
• The Egypt Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 17.06 million in 2024.
• The South Africa Radiopharmaceuticals market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 25.68 million in 2024. Radiopharmaceuticals sales flourish in South Africa due to the healthcare infrastructure.
• The Turkey Radiopharmaceuticals market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 13.98 million in 2024.
• The Nigeria Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 17.06 million in 2024.
• The Rest of MEA Radiopharmaceuticals market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 19.18 million in 2024.

Radiopharmaceuticals Market Analysis

Radiopharmaceuticals Market Radioisotope Segment Analysis

According to Cognitive Market Research, Technetium 99m stands out as the dominating category. Technetium-99m (Tc-99m) is a pivotal factor riding an increase inside the radiopharmaceuticals market. It is extensively used in nuclear medicinal drug imaging because of its favorable characteristics, such as ideal 1/2-life for imaging processes and flexible binding homes. TC-99 m plays an important role in diagnosing various scientific conditions, which include cardiovascular illnesses and cancers, contributing notably to the increasing call for and adoption of radiopharmaceuticals globally.

Gallium 68 emerges as the fastest-growing category in the Radiopharmaceuticals market. Gallium-68 (Ga-68) is rising as a key driving force inside the radiopharmaceuticals marketplace, mainly within the subject of molecular imaging. It is applied in positron emission tomography (PET) imaging to diagnose and monitor numerous cancers, neuroendocrine tumors, and other conditions. Ga-sixty-eight offers high imaging decisions and efficiency, making it an increasing number followed in clinical settings and contributing to the marketplace's boom globally.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Radiopharmaceuticals Industry. Request a Free Sample PDF!

Radiopharmaceuticals Market Application Segment Analysis

According to Cognitive Market Research, the dominating category is Cancer. The developing occurrence of most cancers internationally is a major aspect driving the growth of the radiopharmaceuticals market. Radiopharmaceuticals play an important function in cancer analysis, staging, and remedy-making plans, offering precise imaging and centered therapy alternatives. Advances in oncology studies, coupled with increasing awareness and adoption of personalized medication tactics, in addition, contribute to the rising call for radiopharmaceuticals in cancer care.

The fastest-growing category in the Radiopharmaceuticals market is Cardiology Cardiology is a widespread driving force of boom inside the radiopharmaceuticals market, particularly in the diagnosis and control of cardiovascular illnesses. Radiopharmaceuticals enable precise imaging of myocardial perfusion and features, aiding in the early detection of coronary heart situations and guiding therapeutic selections. Advances in cardiac imaging strategies, coupled with rising cardiovascular disease prevalence and growing old populations, underscore the increasing role of radiopharmaceuticals in cardiology.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Radiopharmaceuticals Application Segment Analysis

According to Cognitive Market Research, the dominating category is Hospitals and Clinics. Hospitals and clinics are pivotal in driving the increase of the radiopharmaceuticals marketplace, serving as the number one points of care in which these specialized sellers are administered for diagnostic imaging and therapeutic functions. Increasing patient admissions, advancements in medical technology, and rising demand for customized healthcare solutions all contribute to the increasing usage of radiopharmaceuticals in medical settings, helping the marketplace boom globally.

The fastest-growing category in the Radiopharmaceuticals market is Medical Imaging Centers. Medical imaging centers are playing a crucial function in the growth of the radiopharmaceuticals market by providing specialized imaging offerings, including PET and SPECT scans. These facilities cater to the growing demand for particular diagnostic tools in oncology, neurology, and cardiology. Advances in imaging technology and the potential to deliver focused remedies are driving the adoption of radiopharmaceuticals in these centers.

• Cancer
• Prostate Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Lung Cancer
• Brain Tumors
• Others
• Cardiology
• Others
• Neurological Applications
• Other Applications

Radiopharmaceuticals End User Segment Analysis

• Hospitals and Clinics
• Medical Imaging Centers
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion